Rockwell Medical to Buy Vantive's Hemodialysis Business for $125 Million Plus Debt-Style Financing
The deal is financed mainly by seller loans and a $25 million convertible note, with up to $45 million more in earnout payments tied to performance.
Rockwell Medical RMTI
Rockwell Medical, Inc. · Nasdaq · Pharmaceutical Preparations
$8.09+17.08%close on Nov. 3, 2026 · volume 63K · Yahoo Finance
Price, last 51 sessions
Our coverage
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 1, 2026 | Mark Strobeck President and CEO, director | Sold 10b5-1 plan | 1,000 | $8.42 | $8,420 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 5 →Entry into a material definitive agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedRockwell Medical Agrees to Acquire Vantive Hemodialysis Business for $125 Million Base Price, Funded Mostly by Vantive Seller Debt and Convertible Note
Regulation FD disclosure · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits